Breaking News, Promotions & Moves

PCI Bolsters Global Clinical Operations and Supply

Brian Keesee to lead PCI's Global Clinical Operations function

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Pharmaceutical outsourcing provider PCI Pharma Services has promoted Brian Keesee to the new position of vice president and general manager, global clinical operations and supply. Mr. Keesee’s appointment demonstrates PCI’s ongoing investment in its clinical services offering; this new role reflects the continued growth of this division of the PCI Pharma Services business, and is in direct response to customer requirements.

Based at PCI’s Rockford, IL clinical center of excellence, Mr. Keesee will oversee PCI’s various clinical departments and execute the strategic plan to evaluate, improve and bring further harmonization to its wider operations, reflecting the organization’s commitment to offering full-service solutions to its clients globally, irrespective of where a project is delivered. He will drive overall project management, overseeing storage and distribution services, quality control and operation of the business to ensure the clinical team continues to achieve their number one commitment of delivering exceptional customer service for PCI’s clients across the world.

“We are delighted to have Brian in this new role, which is warranted due to the significant growth of our clinical services business globally,” said Brad Payne, senior vice president global operations, PCI. “This position will ensure global oversight and harmonization of our Clinical operations and supply functions. His significant experience and skills will serve the business well; driving and supporting the sales strategy, new opportunities, project management and team development in his leadership of this important function.”  
 
PCI continues to make considerable investment across its global clinical supply business, recently opening a new building at its Bridgend, UK European Center of Excellence. In addition, PCI announced the acquisition of Australian based PPP, specializing in expediting of Phase I clinical study in the Australian and Asia Pacific region, expanding PCI’s global reach and market access.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters